Importantly, knockdown of MASTL reduced viability of thyroid cancer cells without significantly affecting normal cell proliferation (Anania et al., 2015), suggesting that MASTL inhibitors may be relatively non-toxic. This evidence concerns the gene MASTL and thyroid cancer.